OMER - OMEROS CORP
6.18
-0.130 -2.104%
Share volume: 521,705
Last Updated: 05-09-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.09%
PREVIOUS CLOSE
CHG
CHG%
$6.31
-0.13
-0.02%
Summary score
47%
Profitability
37%
Dept financing
50%
Liquidity
55%
Performance
55%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 30-Sep-2013 - 30-Sep-2017
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
18.01%
Return on assets
-15.96%
Return on sales
-79.11%
Return on invested capital
169.78%
Total debt ratio
150.58%
Debt ratio change over timeo
0%
Current Ratio
3.49%
Quick Ratio
3.44%
Cash Position Ratio
0.21%
Short-term ratios 30-Sep-2016 - 30-Sep-2017
The data are presented for the financials results of the quarters of the last year.
Return on equity
7.18%
Return on assets
-15.82%
Return on sales
-72.23%
Return on invested capital
123.7%
Total debt ratio
155.4%
Debt ratio change over timeo
0%
Current Ratio
3.42%
Quick Ratio
3.37%
Cash Position Ratio
0.1%
Last quarter ratios 30-Sep-2017
The data are presented for the financials results of the last quarter.
Return on equity
-81.23%
Return on assets
-4.07%
Return on sales
-23.59%
Return on invested capital
43.83%
Total debt ratio
92.66%
Debt ratio change over time
0%
Current Ratio
4.78%
Quick Ratio
4.74%
Cash Position Ratio
0.04%
Performance ratios (change over 4 years) 30-Sep-2013 - 30-Sep-2017
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | OMER | LLY | JNJ | NVO |
|---|---|---|---|---|
| Return on equity | 18.01% | 4.12% | 5.6% | 21.75% |
| Return on assets | -15.96% | 2.87% | 3.58% | 12.86% |
| Return on sales | -79.11% | 20.56% | 28.52% | 43.62% |
| Return on invested capital | 169.78% | 4.34% | 6.5% | -154.84% |
| Profitability | 46% | 23% | 31% | 75% |
| Total debt ratio | 150.58% | 63.22% | 51.03% | 53.2% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 50% | 10% | 8% | 9% |
| Current Ratio | 3.42% | 1.35% | 1.91% | 1.25% |
| Quick Ratio | 3.37% | 0.99% | 1.59% | 0.93% |
| Cash Position Ratio | 0.1% | 0.31% | 0.62% | 0.41% |
| Liquididy | 58% | 30% | 53% | 31% |
| Short-term ratios | OMER | LLY | JNJ | NVO |
|---|---|---|---|---|
| Return on equity | 7.18% | 3.9% | 5.53% | 21.28% |
| Return on assets | -15.82% | 2.93% | 3.51% | 12.59% |
| Return on sales | -72.23% | 20.94% | 28.11% | 43.44% |
| Return on invested capital | 123.7% | 4.21% | 6.14% | -151.68% |
| Profitability | 33% | 23% | 31% | 75% |
| Total debt ratio | 155.4% | 64.39% | 51.75% | 53.34% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 50% | 10% | 8% | 9% |
| Current Ratio | 3.42% | 1.35% | 1.91% | 1.25% |
| Quick Ratio | 3.37% | 0.99% | 1.59% | 0.93% |
| Cash Position Ratio | 0.1% | 0.31% | 0.62% | 0.41% |
| Liquididy | 54% | 30% | 51% | 33% |
